| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/28/2004 | CN1471526A Dioxolane analogs for improved inter-cellular delivery |
| 01/28/2004 | CN1471524A Novel farnesyl protein transferase inhibitors as antitumor |
| 01/28/2004 | CN1471523A Imidazole derivatives as Raf kinase inhibitors |
| 01/28/2004 | CN1471522A Cholesterol lowering benzo [b] thiophenes and benzo[d] isothiazoles |
| 01/28/2004 | CN1471521A Amino alkoxybenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same |
| 01/28/2004 | CN1471520A Aminoalkyl benzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 01/28/2004 | CN1471519A Amino alkyenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 01/28/2004 | CN1471512A Gem-substituted ± ¢ ²3 integrin antagonists |
| 01/28/2004 | CN1471508A Selective androgen receptor modulators and methods of use thereof |
| 01/28/2004 | CN1471408A Methods of treatment of a BCL-2 disorder using BCL-2 antisense oligomers |
| 01/28/2004 | CN1471407A Multifunctional nano device platform |
| 01/28/2004 | CN1471400A Combination therapy for the treatment of estrogen-sensitive disease |
| 01/28/2004 | CN1471396A A combination comprising camptothecin and a stilbene derivative for the treatment of cancer |
| 01/28/2004 | CN1471387A Oral dosage self-emulsifying formulations of pyranone proteinase inhibitors |
| 01/28/2004 | CN1470530A Humanmachine tumour monoclonal antibody, and its preparing method and use |
| 01/28/2004 | CN1470516A Gambogic aid compound complex, its preparing method and medicinal composition containing the complex as active ingredient |
| 01/28/2004 | CN1470513A Total alkaloid with anticancer activity and its formulation |
| 01/28/2004 | CN1470290A Radioactive nano ferror nuclein medicine and its medical use |
| 01/28/2004 | CN1470289A Polymeric nano medicine carrier and preparation preparing method |
| 01/28/2004 | CN1470288A Medical use of paramagnetic material |
| 01/28/2004 | CN1470276A Medicament for treating cancer |
| 01/28/2004 | CN1470264A Chinese medicinal decoction for preventing and treating cancer |
| 01/28/2004 | CN1470260A Tumor-diminishing pills |
| 01/28/2004 | CN1470252A Anti-cancer and tumor-diminishing compound preparation of Chinese medicine and its preparation method |
| 01/28/2004 | CN1470243A Use of N-acetyl-D-aminoglucose in preparation of anti-tumor and anti-tumor-transition medicines |
| 01/28/2004 | CN1136226C Synthesis and anticancer activity of conjugated phospholipid compounds |
| 01/28/2004 | CN1136189C Substituted heterocyclic compounds, preparing method thereof and pharmaceutical composition containig them |
| 01/28/2004 | CN1135977C Application of malaridine in preparing antitumor medicine and tumor tolerance-reversing medicine |
| 01/27/2004 | US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |
| 01/27/2004 | US6683196 Reacting racemic beta-lactam with lithium- 7-protected baccatin iii- complex to form 3'desphenyl-3'-(1-napthyl)taxol; antitumor agents |
| 01/27/2004 | US6683183 Bicyclic heterocycles that inhibit cyclin-dependent kinase or tyrosine kinase enzymes, or both, for treatment of proliferative disorders |
| 01/27/2004 | US6683163 Monitoring angiogenesis factor |
| 01/27/2004 | US6683162 Especially an actinium isotope complex of 2-(p-isothiocyanatobenzyl)-1,4,7,10-tetraazocyclododecane-1,4,7,10 -tetraacetic acid that is covalently bonded to an antibody or fragment |
| 01/27/2004 | US6683109 Condensation derivatives of thiocolchicine and baccatin as antitumor agents |
| 01/27/2004 | US6683095 CDK inhibitors having 3-hydroxychromen-4-one structure |
| 01/27/2004 | US6683093 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |
| 01/27/2004 | US6683088 Sulfonamido ether substituted imidazoquinolines |
| 01/27/2004 | US6683083 Using less toxic agents such as 1-(1-4-(diphenylmethyl)-piperazinyl)-3-(1-(4-(4-chlorophenyl)-4 -hydroxy)piperidinyl)-2-propanol; inhibiting fibroblast proliferation |
| 01/27/2004 | US6683082 3-hetero-arylidene-2-indolinone compounds; anticancer agents |
| 01/27/2004 | US6683078 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/27/2004 | US6683060 Chelating zinc with 1-(3,4-dihydroxy-5-(2-hydroxyethyl)-tetrahydrofuran-2-yl)pyrimidine -2,4(1h,3h)-dione; ovarian cancer |
| 01/27/2004 | US6683059 Constructs for suppression of oncogenic transformation, tumorigenesis and metastasis |
| 01/27/2004 | US6683051 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor |
| 01/27/2004 | US6682902 Human extracellular matrix polypeptides; polynucleotides; expression vectors; host cells; medical diagnosis; prostate cancer; detection of metastasis |
| 01/27/2004 | US6682734 Anti-cd20 derived from transfectoma having atcc deposit numbers 69119 and hbe 1388 respectively; depletion of peripheral blood b cells |
| 01/27/2004 | CA2254772C Liposomal antineoplaston therapies with markedly improved antineoplastic activity |
| 01/27/2004 | CA2214720C Arylsulfonylamino hydroxamic acid derivatives |
| 01/27/2004 | CA2092979C Cyclodextrin inclusion complex of paclitaxel, and method for its production and its use |
| 01/27/2004 | CA2069483C Steroid sulphatase inhibitors |
| 01/27/2004 | CA2002607C Natural killer stimulatory factor |
| 01/22/2004 | WO2004008147A2 Diagnosis and prevention of cancer cell invasion |
| 01/22/2004 | WO2004008137A2 Diagnosis and therapy of breast tumours resistant to antiestrogen treatment |
| 01/22/2004 | WO2004008101A2 The use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates |
| 01/22/2004 | WO2004007770A2 Method for diagnosis of intestinal-type gastric tumors |
| 01/22/2004 | WO2004007735A1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 01/22/2004 | WO2004007734A1 Her-2/neu dna vaccine having anti-cancer activity |
| 01/22/2004 | WO2004007723A2 Genes |
| 01/22/2004 | WO2004007719A1 Use of sumo- and ubiquitin-modified pcna for detection and channeling of dna transaction pathways |
| 01/22/2004 | WO2004007717A1 Proteomic screen to identify disease-related biological molecules and inhibitors thereto |
| 01/22/2004 | WO2004007709A2 Production of polyketides |
| 01/22/2004 | WO2004007703A1 Replicability virus which can express anti-tumour antibody with high efficiency and the use of it |
| 01/22/2004 | WO2004007550A1 Mcam inhibitors |
| 01/22/2004 | WO2004007543A1 Altered insulin-like growth factor binding proteins |
| 01/22/2004 | WO2004007531A2 Activated checkpoint therapy and methods of use thereof |
| 01/22/2004 | WO2004007517A1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 01/22/2004 | WO2004007504A1 Heterobicyclic pyrazole derivatives as kinase inhibitors |
| 01/22/2004 | WO2004007502A1 Furopyridine and furopyrimidine derivatives for the treatment of hyper-proliferative disorders |
| 01/22/2004 | WO2004007501A1 Biologically active compounds |
| 01/22/2004 | WO2004007499A1 3-furanyl analogs of toxoflavine as kinase inhibitors |
| 01/22/2004 | WO2004007498A2 3-phenyl analogs of toxoflavine as kinase inhibitors |
| 01/22/2004 | WO2004007492A1 Novel macrocycles for the treatment of cancer |
| 01/22/2004 | WO2004007491A1 Azolidinone-vinyl fused-benzene derivatives |
| 01/22/2004 | WO2004007483A1 Novel macrocycles for the treatment of cancer diseases |
| 01/22/2004 | WO2004007481A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis relates disorders |
| 01/22/2004 | WO2004007480A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 01/22/2004 | WO2004007479A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 01/22/2004 | WO2004007478A2 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use |
| 01/22/2004 | WO2004007476A1 Gesellschaft für biotechnologische forschung mbh (gbf) |
| 01/22/2004 | WO2004007473A1 Process for preparing of paclitaxel |
| 01/22/2004 | WO2004007472A1 Ccr4 antagonist and medicinal use thereof |
| 01/22/2004 | WO2004007471A1 N-phenyl-(2r,5s)dimethylpiperadine derivative |
| 01/22/2004 | WO2004007470A1 Novel anthracene derivatives and the use thereof as a medicament |
| 01/22/2004 | WO2004007468A1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/22/2004 | WO2004007458A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
| 01/22/2004 | WO2004007457A2 Substituted benzylamine derivatives and methods of use |
| 01/22/2004 | WO2004007454A1 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 01/22/2004 | WO2004007453A1 Piperidinetriol derivatives as inhibitors of glycosylceramide synthase |
| 01/22/2004 | WO2004007437A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 01/22/2004 | WO2004007430A2 Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands |
| 01/22/2004 | WO2004006966A1 Steroid conjugates, preparation thereof and the use thereof |
| 01/22/2004 | WO2004006958A1 Stable pharmaceutical composition comprising erythropoietin |
| 01/22/2004 | WO2004006938A1 Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations |
| 01/22/2004 | WO2004006937A2 Novel pharmaceutical compositions based on 5-alpha-reductase inhibitors and uses of same |
| 01/22/2004 | WO2004006936A1 Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy |
| 01/22/2004 | WO2004006928A1 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride |
| 01/22/2004 | WO2004006925A1 N-sulfonylpiperidines as metalloproteinase inhibitors (tace) |
| 01/22/2004 | WO2004006909A1 Combination of chemotherapeutic drugs for increasing antitumor activity |
| 01/22/2004 | WO2004006897A1 Aqueous dispersions of nanometric or micrometric particles for encapsulating chemical compounds |
| 01/22/2004 | WO2004006895A1 Lasofoxifene tablet and its coating |